Delivery Order SPE2DB22D9353-SPE2DB25FX1VK

Award Date 4/21/25
Potential Completion Date 4/22/25
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $6,837.40, is for the delivery of 4,567,454,051 units of the Menveo A-C-Y-W-135 diphtheria vaccine in 0.5 ml vials. The contract has an ultimate completion date of March 5, 2025 and is not associated with any set-aside designation. DMS Pharmaceutical Group...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,467.32 firm fixed-price contract is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a specialized pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order valued at $25,942.32 for the supply of Menveo A-C-Y-W immunization kits. The contract has an ultimate completion date of April 24, 2025 and is a firm fixed-price delivery order. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of MENVEO A-C-Y-W KIT (2 VIALS), a pharmaceutical product, with a ceiling value of $9,357.12 and an ultimate completion date of August 10, 2023. The contract is a firm fixed-price delivery order and is not set aside for any particular business designation. DMS...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for MENVEO A-C-Y-W KIT (2 VIALS), valued at $3,898.80 with a completion date of August 10, 2023. The order was issued under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the...
This $27,477.72 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccines, with an ultimate completion date of August 7, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $8,457.90, is for the delivery of Menveo A-C-Y-W Kits, which are specialized pharmaceutical products. The contract is a firm fixed-price delivery order and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is a Delivery Order under the SPE2DB program, valued at $3,603.10, for the supply of MENVEO A-C-Y-W KIT (2 VIALS). The contract has a period of performance through April 17, 2025 and is a Firm Fixed Price delivery order. DMS Pharmaceutical Group Inc. is an experienced federal contractor, holding a $499,999,999...
This federal contract award, valued at $3,603.10, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of MENVEO A-C-Y-W KIT (2 VIALS), a pharmaceutical product, with a completion date of April 17, 2025. This is a firm fixed-price delivery order contract, and there is no set-aside designation mentioned. DMS Pharmaceutical Group Inc. holds a significant single-award...
Defense Logistics Agency Troop Support Medical has awarded DMS Pharmaceutical Group Inc. a $6,236.64 firm fixed price delivery order to supply one vial of MENVEO, a meningococcal vaccine. The delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with Defense Logistics Agency to provide various pharmaceuticals and medical supplies with a potential value of up to $5 million through December 2025. No set-aside designation was used for this award. DMS...
  • SPE2DB22D9353
    Indefinite Delivery Contract
  • SPE2DB22D9353-SPE2DB25FX1VK
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of MENVEO A-C-Y-W vaccines, with a ceiling value of $3,603.10 and a period of performance through April 2025.

DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, in support of the medical supply needs of military health facilities worldwide. This positioning establishes DMS Pharmaceutical Group as a critical supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites.

Generated 7/21/25, 7:41 PM